UnitedHealth Group (NYSE: UNH) Optum CEO sells stock worth $205,000

Rhea-AI Filing Summary

UnitedHealth Group executive Patrick Hugh Conway, Chief Executive Officer of Optum, reported a sale of 500 shares of Common Stock on 2026-08-05. The shares were sold in a sale in open market or private transaction at $410.00 per share, for an implied value of about $205,000. Following this transaction, he directly holds 16,496.797 shares of UnitedHealth Group common stock. The Rule 10b5-1 trading-plan checkbox was not marked as affirmed for this sale.

Insider Trade Summary

Net Seller: 500 shares

Net Sell 1 txn

Insider Conway Patrick Hugh

Role Chief Executive Officer, Optum

Sold 500 shs ($205K)

Type	Security	Shares	Price	Value
Sale	Common Stock	500	$410.00	$205K

Holdings After Transaction: Common Stock — 16,496.797 shares (Direct)

Key Figures

Shares sold: 500 shares Sale price per share: $410.00 per share Implied sale value: $205,000 +1 more

4 metrics

Shares sold 500 shares Non-derivative Common Stock sale on 2026-08-05

Sale price per share $410.00 per share Price for Common Stock sale on 2026-08-05

Implied sale value $205,000 500 shares sold at $410.00 per share

Shares held after transaction 16,496.797 shares Directly owned UnitedHealth Group common stock after sale

Key Terms

Sale in open market or private transaction, Rule 10b5-1 plan, direct ownership

3 terms

Sale in open market or private transaction financial

"Transaction code description is “Sale in open market or private transaction”."

Rule 10b5-1 plan regulatory

"The Rule 10b5-1 checkbox was not marked as affirmed for this sale."

A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.

direct ownership financial

"Shares are reported as direct ownership with ownership code D."

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/07/2026 - 04:17 PM Accepted by SEC EDGAR 08/07/2026 - 04:16 PM Learn about SEC filing dates

FAQ

What insider transaction did UNH executive Patrick Hugh Conway report?

Patrick Hugh Conway, Optum’s Chief Executive Officer, reported a sale of 500 shares of UnitedHealth Group common stock. The non-derivative transaction occurred on 2026-08-05 and was reported as a sale in open market or private transaction.

At what price did Patrick Hugh Conway sell UnitedHealth (UNH) shares?

He sold 500 shares at $410.00 per share, implying proceeds of roughly $205,000. The transaction was classified as Common Stock, non-derivative, and used the SEC’s description “Sale in open market or private transaction.”

How many UnitedHealth (UNH) shares does Patrick Hugh Conway hold after the sale?

After the reported sale, Patrick Hugh Conway directly holds 16,496.797 shares of UnitedHealth Group common stock. This post-transaction balance is disclosed in the Form 4 as direct ownership under ownership code D.

Was Patrick Hugh Conway’s UNH stock sale under a Rule 10b5-1 plan?

The Form 4 indicates the Rule 10b5-1 checkbox was not affirmed, so the sale was not reported as made under a Rule 10b5-1 trading plan. No footnote in this filing states otherwise for the 500-share transaction.

What role does Patrick Hugh Conway have at UnitedHealth (UNH)?

Patrick Hugh Conway is listed as Chief Executive Officer, Optum, an executive officer position within UnitedHealth Group. His officer status and title are disclosed alongside the reported 500-share Common Stock sale.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Conway Patrick Hugh

(Last) (First) (Middle)

C/O UNITEDHEALTH GROUP INCORPORATED

1 HEALTH DRIVE

(Street)

EDEN PRAIRIE MINNESOTA 55344

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
UNITEDHEALTH GROUP INC [ UNH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer, Optum

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/05/2026		S		500	D	$410	16,496.797	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	Faraz A. Choudhry, Attorney-in-Fact for Patrick H. Conway	08/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)